These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus. Tseng CH. Sci Rep; 2021 Jun 11; 11(1):12400. PubMed ID: 34117321 [Abstract] [Full Text] [Related]
4. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus. Tseng CH. Aging (Albany NY); 2016 Aug 11; 8(8):1636-49. PubMed ID: 27587088 [Abstract] [Full Text] [Related]
5. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus. Tseng CH. Metabolism; 2018 Aug 11; 85():223-226. PubMed ID: 29729227 [Abstract] [Full Text] [Related]
7. Use of metformin and risk of kidney cancer in patients with type 2 diabetes. Tseng CH. Eur J Cancer; 2016 Jan 11; 52():19-25. PubMed ID: 26630530 [Abstract] [Full Text] [Related]
11. Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus. Tseng CH. Eur J Endocrinol; 2019 Jun 01; 180(6):365-372. PubMed ID: 30986765 [Abstract] [Full Text] [Related]
12. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis. Tseng CH. Diabetes Metab; 2017 Oct 01; 43(5):438-445. PubMed ID: 28438547 [Abstract] [Full Text] [Related]
15. Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis. Tseng CH. J Am Heart Assoc; 2019 Nov 05; 8(21):e011640. PubMed ID: 31630591 [Abstract] [Full Text] [Related]